查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1593761

IVF 市場評估：按產品類型、週期類型、治療、分銷管道和地區劃分的機會和預測（2017-2031 年）

In-Vitro Fertilization Market Assessment, By Product, By Type of Cycle, By Procedure, By Distribution Channel, By Region, Opportunities and Forecast, 2017-2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 230 Pages | 商品交期: 3-5個工作天內

價格

全球 IVF 市場規模預計將從 2023 年的 290.5 億美元增長到 2031 年的 518.9 億美元，預測期內複合年增長率為 7.52%。

由於投資者和市場參與者的意識不斷增強以及興趣不斷增長，體外受精的市場需求預計將在預測期內呈指數級增長。

不孕​​症可能是由多種生活習慣引起的，例如吸煙、酗酒和肥胖。不孕症是一個全球性的健康問題，影響著全世界數百萬人的育齡期。例如，根據世界衛生組織 (WHO) 2023 年 4 月發佈的報告，約 17.5% 的成年人口，即全球約六分之一的人患有不孕不育問題。高收入國家不孕症的終生盛行率為 17.8%，低收入和中等收入國家為 16.5%。

本報告調查了全球IVF 市場，包括市場定義和概述、市場規模趨勢和預測、各個細分市場/地區/主要國家的詳細分析、行業結構以及對市場成長的影響，它總結了因素分析、案例研究。

目錄

第一章專案範圍與定義

第二章研究方法

第 3 章執行摘要

第四章全球IVF市場展望

  • 市場規模分析與預測
  • 市佔率分析/預測
    • 按產品
    • 按自行車類型
    • 透過治療
    • 按分銷管道
    • 按地區
    • 按公司劃分的市佔率分析
  • 市場地圖分析

第五章北美IVF市場展望

  • 市場規模分析與預測
  • 市佔率分析/預測
  • 國家市場評估
    • 美國
    • 加拿大
    • 墨西哥

第六章歐洲 IVF 市場展望

  • 德國
  • 法國
  • 義大利
  • 英國
  • 俄羅斯
  • 荷蘭
  • 西班牙
  • 波蘭

第七章亞太IVF市場展望

  • 印度
  • 中國
  • 日本
  • 澳大利亞
  • 越南
  • 韓國
  • 印尼
  • 菲律賓

第八章南美IVF市場展望

  • 巴西
  • 阿根廷

第九章中東與非洲IVF市場展望

  • 沙烏地阿拉伯
  • 阿聯酋
  • 南非
  • 以色列

第10章供需分析

第 11 章匯入/匯出分析

第十二章價值鏈分析

第 13 章波特五力分析

第14章PESTLE分析

第十五章價格分析

第 16 章市場動態

  • 市場驅動因素
  • 市場課題

第十七章市場趨勢與發展

第 18 章法律與監管架構/創新

  • 監理機關的核准

第十九章專利狀況

第 20 章個案研究

第21章競爭態勢

  • 前 5 名市場領導者的競爭矩陣
  • 前 5 名的公司的 SWOT 分析
  • 前10名企業狀況
    • Thermo Fisher Scientific, Inc.
    • Hamilton Thorne, Inc.
    • Cook Medical Inc.
    • Cooper Surgical Inc.
    • Bayer AG
    • Boston IVF, LLC.
    • Genea Pty Limited
    • Kitazato Corporation
    • Shady Grove Fertility
    • Corning Incorporated

第 22 章策略建議

第23章關於我們公司/免責聲明

Product Code: MX12273

Global in-vitro fertilization market is projected to witness a CAGR of 7.52% during the forecast period 2024-2031, growing from USD 29.05 billion in 2023 to USD 51.89 billion in 2031. The market demand for in-vitro fertilization is anticipated to thrive drastically in the forecast years due to rising awareness and the growing interest of investors and market players.

In-vitro fertilization is one of the types of assisted reproductive technology and is the most common approach made in the care of patients with difficulty in conceiving. This is a procedure in which eggs are removed from a woman's ovary and then combined with sperm outside the body to form embryos. The embryos are grown in the laboratory for a few days and then either placed in a woman's uterus or cryopreserved (frozen) for future use, which is also called in-vitro fertilization.

Infertility could be attributable to various lifestyle factors, including smoking, heavy alcohol consumption, and obesity. Infertility is a global health issue affecting millions of people of reproductive age worldwide. For instance, according to a report published by the World Health Organization (WHO) in April 2023, around 17.5% of the adult population - roughly 1 in 6 worldwide suffer from infertility problems. The new estimates indicate that limited regional difference exists in the prevalence of infertility. The rates were quite balanced among high-, middle- and low-income countries, making it a major burden for healthcare across the globe. The report further stated that the lifetime prevalence of infertility was at 17.8% among high-income countries, and among low- and middle-income countries, was at 16.5%. For instance, in May 2023, Artificial Intelligence In-vitro Fertilization (AIVF) Ltd., a developer of AI-based solutions for in-vitro fertilization clinics, and Genea Biomedx Pty Ltd., a global provider of medical devices for IVF laboratories, announced the launch of their integrated system. The new consolidated solution is aimed at providing safe personalized, optimized IVF care to a mass population.

Increased Prevalence of Infertility Rate to Support the Growth of IVF Market

Increased prevalence of infertility is one of the major factors which led to the growth of the market for in-vitro fertilization. Various socioeconomic factors, like late marriage and childbirth, and lifestyle factors, like bad diet, obesity, and stress, have led to higher rates of infertility across the world. Moreover, certain medical conditions, like polycystic ovary syndrome, endometriosis, and male infertility, are also becoming increasingly perceived, with these factors often complicating conception. Advanced medical technology, fertility options awareness, and the changing nature of social values toward assisted reproduction will only augment these increasing demands for in-vitro fertilization services. People and couples put more emphasis on planning for family-building and finding necessary fertility solutions. Thus, to cater to the increasing demand, fertility clinics are offering a wide portfolio of services and investing in various advanced technologies to ensure higher success rates, such as genetic screening and enhanced embryo culture techniques. This increased demand fuels growth for the IVF market. For instance, in August 2024, Fresenius SE & Co. KGaA's U.S.-based subsidiary - Fresenius Kabi USA launched U.S. Food and Drug Administration (FDA) approved Cetrorelix Acetate injection kit. Cetrorelix Acetate injection is a prescription medicine for the hormonal treatment of ovarian stimulation.

Awareness and Advancements in Technology to Drive IVF Market Growth

Awareness and technological advances are vital drivers in the IVF market. The increase in public knowledge regarding infertility and the availability of treatment options has reflected greater acceptance of assisted reproductive technologies. Advances in technology, including better techniques for embryo culture, preimplantation genetic testing, and improvements in cryopreservation, have greatly increased the success rates of IVF treatment. This also makes the procedures more effective and can increase the number of options available to a patient, including genetic screening and the possibility of freezing eggs or embryos for future use. Fertility clinics increasingly embrace high-tech facilities to attract and retain patients and further foster market growth. With continued spreading awareness and technological advancements, the IVF market will expand steadily in the future. For instance, in December 2023, the U.S. FDA cleared the first over-the-counter artificial insemination kit manufactured by Mosie Inc. The approval of the artificial insemination kit is expected to drive the market by making fertility treatments more accessible, affordable, and inclusive.

Culture Media Segment to Dominate the In-Vitro Fertilization Market

The culture media segment is forecast to dominate the market for in-vitro fertilization as it represents a crucial component in support of embryonic development and significant improvement of success rates. The culture media provides the minimum amount of nutrients and optimal conditions for embryos to be cultured outside the human body, making it an indispensable part of the IVF process. Advanced formulation techniques have ensured that these media work well and are tailored to different embryo development stages. However, the increasing impetus around personalized medicine and precision reproductive care requires demand for well-designed culture media for each patient that will ensure superior results. Accordingly, with increasing fertility treatments around the world and increasing cycles of IVF, the demand for high-quality culture media grows further.

Consequently, with unrelenting research and development, the growth in the culture media market is foreseen to be sturdy, which places it in a great position to fuel general growth in the IVF market. For instance, in July 2022, FUJIFILM Irvine Scientific, which develops and manufactures cell culture media and assisted reproductive technologies, announced the launch of its Heavy Oil for Embryo Culture, a sterile mineral oil that comes with optimal weight viscosity for the perfect balance of ease of use and protection.

North America Dominates In-Vitro Fertilization Market

North America is leading the IVF market because of advanced medical technology, higher fertility treatment awareness, and strong healthcare infrastructure. It has a huge number of fertility clinics with specialized staff and well-equipped professionals. According to clinic-specific assisted reproductive technologies (ART) data released by the Society for Assisted Reproductive Technology (SART). In 2022, the number of IVF babies increased by 2.5%, from 89,208 in 2021 to 91,771 in 2022. That represents 2.5% of all births in the U.S. and translates to successful ART cycles. Increased reports of cycle numbers point to the continued steady growth in demand for fertility services, even hostile legislation and threats of political interference. The total number of IVF cycles performed at the 368-member clinics of the Society for Assisted Reproductive Technology (SART) has grown by over 6% from 2021, from 368,502 in 2021 to 389,993 in 2022.

For instance, in February 2024, Femasys Inc., a biomedical company, received approval from the FDA for FemaSeed, a First-Line Infertility Treatment Option. Femasys is preparing for the commercial launch of FemaSeed in the U.S. There is a rise in the incidence of infertility due to late pregnancies and lifestyle factors and increased demand for assisted reproductive technology. Available treatment options, favorable policies, and certain insurance coverage contribute to more promising prospects for the growth of this market. Moreover, further research and development in applied reproductive technologies, including embryo culture techniques and genetic screening, keeps North America on top of the IVF industry. As societal attitudes toward fertility treatment increasingly change, such factors as the growing acceptance of fertility treatments show that North America will continue to dominate the market for IVF for the foreseeable future.

Future Market Scenario (2024-2031F)

The future market scenario of the in-vitro fertilization (IVF) market is poised for significant growth, driven by increased awareness of reproductive health, technological advancement, greater communication around reproductive health issues, and better social attitudes. With rising acceptance and a growing ability to access fertility treatments, many couples are looking toward IVF as a viable option for building families. The others include the improved success rate through technological advancement in embryo selection, advanced genetic screening, and even better culture media, therefore leading to tailoring treatment plans to improve further patient experiences, where focus is increasingly placed on personalized medicine. Another area that continues to expand is fertility preservation services, specifically egg and sperm freezing, which are adopted by younger demographics. For instance, in April 2023, Cryoport, Inc. signed a 3-year agreement with Boston IVF, LLC, a pioneer in reproductive healthcare and innovative research and one of the world's most experienced fertility treatment providers.

Key Players Landscape and Outlook

In-vitro fertilization market is highly dynamic, market activity reported in recent years includes business agreements, collaborations, and regulatory approvals of products of market players. The market fosters several smaller players as well, which operate through collaborations with other players to cater to a larger market.

For instance, in May 2023, U.S. Fertility, the largest partnership of physician-owned fertility practices in the United States, announced that it entered into a definitive agreement to join forces with Ovation Fertility. The companies signed the agreement and completed a successful federal regulatory evaluation process, merging to form the leading fertility platform in the U.S. Fertility and Ovation deliver advanced fertility care through more than 90 locations and 28 laboratories.

Moreover, in February 2024, Fertility Centers of New England, Inc. (FCNE) announced the acquisition of Fertility Solutions Inc., a distinguished fertility clinic with locations in Massachusetts and Rhode Island. This acquisition marked a significant milestone in FCNE's mission to broaden patient access to cutting-edge fertility treatments.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. Global In-Vitro Fertilization Market Outlook, 2017-2031F

  • 4.1. Market Size Analysis & Forecast
    • 4.1.1. By Value
  • 4.2. Market Share Analysis & Forecast
    • 4.2.1. By Product
      • 4.2.1.1. Equipment
      • 4.2.1.2. Reagents and Culture Media
    • 4.2.2. By Type of Cycle
      • 4.2.2.1. Fresh Donor
      • 4.2.2.2. Frozen Donor
      • 4.2.2.3. Fresh Non-Donor
      • 4.2.2.4. Frozen Non-Donor
    • 4.2.3. By Procedure
      • 4.2.3.1. Conventional In-Vitro Fertilization
      • 4.2.3.2. In-Vitro Fertilization with ICSI
      • 4.2.3.3. In-Vitro Fertilization with Donor Eggs
      • 4.2.3.4. Minimal In-Vitro Fertilization
      • 4.2.3.5. Others
    • 4.2.4. By Distribution
      • 4.2.4.1. Fertility Clinics
      • 4.2.4.2. Hospitals
      • 4.2.4.3. Surgical Centers
      • 4.2.4.4. Others
    • 4.2.5. By Region
      • 4.2.5.1. North America
      • 4.2.5.2. Europe
      • 4.2.5.3. Asia-Pacific
      • 4.2.5.4. South America
      • 4.2.5.5. Middle East and Africa
    • 4.2.6. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2023)
  • 4.3. Market Map Analysis, 2023
    • 4.3.1. By Product
    • 4.3.2. By Type of Cycle
    • 4.3.3. By Procedure
    • 4.3.4. By Distribution
    • 4.3.5. By Region

5. North America In-Vitro Fertilization Market Outlook, 2017-2031F*

  • 5.1. Market Size Analysis & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share Analysis & Forecast
    • 5.2.1. By Product
      • 5.2.1.1. Equipment
      • 5.2.1.2. Reagents and Culture Media
    • 5.2.2. By Type of Cycle
      • 5.2.2.1. Fresh Donor
      • 5.2.2.2. Frozen Donor
      • 5.2.2.3. Fresh Non-Donor
      • 5.2.2.4. Frozen Non-Donor
    • 5.2.3. By Procedure
      • 5.2.3.1. Conventional In-Vitro Fertilization
      • 5.2.3.2. In-Vitro Fertilization with ICSI
      • 5.2.3.3. In-Vitro Fertilization with Donor Eggs
      • 5.2.3.4. Minimal In-Vitro Fertilization
      • 5.2.3.5. Others
    • 5.2.4. By Distribution
      • 5.2.4.1. Fertility clinics
      • 5.2.4.2. Hospitals
      • 5.2.4.3. Surgical Centers
      • 5.2.4.4. Others
    • 5.2.5. By Country Share
      • 5.2.5.1. United States
      • 5.2.5.2. Canada
      • 5.2.5.3. Mexico
  • 5.3. Country Market Assessment
    • 5.3.1. United States In-Vitro Fertilization Market Outlook, 2017-2031F*
      • 5.3.1.1. Market Size Analysis & Forecast
        • 5.3.1.1.1. By Value
      • 5.3.1.2. Market Share Analysis & Forecast
        • 5.3.1.2.1. By Product
          • 5.3.1.2.1.1. Equipment
          • 5.3.1.2.1.2. Reagents and Culture Media
        • 5.3.1.2.2. By Type of Cycle
          • 5.3.1.2.2.1. Fresh Donor
          • 5.3.1.2.2.2. Frozen Donor
          • 5.3.1.2.2.3. Fresh Non-Donor
          • 5.3.1.2.2.4. Frozen Non-Donor
        • 5.3.1.2.3. By Procedure
          • 5.3.1.2.3.1. Conventional In-Vitro Fertilization
          • 5.3.1.2.3.2. In-Vitro Fertilization with ICSI
          • 5.3.1.2.3.3. In-Vitro Fertilization with Donor Eggs
          • 5.3.1.2.3.4. Minimal In-Vitro Fertilization
          • 5.3.1.2.3.5. Others
        • 5.3.1.2.4. By Distribution
          • 5.3.1.2.4.1. Fertility Clinics
          • 5.3.1.2.4.2. Hospitals
          • 5.3.1.2.4.3. Surgical Centers
          • 5.3.1.2.4.4. Others
    • 5.3.2. Canada
    • 5.3.3. Mexico

All segments will be provided for all regions and countries covered

6. Europe In-Vitro Fertilization Market Outlook, 2017-2031F

  • 6.1. Germany
  • 6.2. France
  • 6.3. Italy
  • 6.4. United Kingdom
  • 6.5. Russia
  • 6.6. Netherlands
  • 6.7. Spain
  • 6.8. Poland

7. Asia-Pacific In-Vitro Fertilization Market Outlook, 2017-2031F

  • 7.1. India
  • 7.2. China
  • 7.3. Japan
  • 7.4. Australia
  • 7.5. Vietnam
  • 7.6. South Korea
  • 7.7. Indonesia
  • 7.8. Philippines

8. South America In-Vitro Fertilization Market Outlook, 2017-2031F

  • 8.1. Brazil
  • 8.2. Argentina

9. Middle East and Africa In-Vitro Fertilization Market Outlook, 2017-2031F

  • 9.1. Saudi Arabia
  • 9.2. UAE
  • 9.3. South Africa
  • 9.4. Israel

10. Demand Supply Analysis

11. Import and Export Analysis

12. Value Chain Analysis

13. Porter's Five Forces Analysis

14. PESTLE Analysis

15. Pricing Analysis

16. Market Dynamics

  • 16.1. Market Drivers
  • 16.2. Market Challenges

17. Market Trends and Developments

18. Regulatory Framework and Innovation

  • 18.1. Regulatory Approvals

19. Patent Landscape

20. Case Studies

21. Competitive Landscape

  • 21.1. Competition Matrix of Top 5 Market Leaders
  • 21.2. SWOT Analysis for Top 5 Players
  • 21.3. Key Players Landscape for Top 10 Market Players
    • 21.3.1. Thermo Fisher Scientific, Inc.
      • 21.3.1.1. Company Details
      • 21.3.1.2. Key Management Personnel
      • 21.3.1.3. Products and Services
      • 21.3.1.4. Financials (As Reported)
      • 21.3.1.5. Key Market Focus and Geographical Presence
      • 21.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisitions
    • 21.3.2. Hamilton Thorne, Inc.
    • 21.3.3. Cook Medical Inc.
    • 21.3.4. Cooper Surgical Inc.
    • 21.3.5. Bayer AG
    • 21.3.6. Boston IVF, LLC.
    • 21.3.7. Genea Pty Limited
    • 21.3.8. Kitazato Corporation
    • 21.3.9. Shady Grove Fertility
    • 21.3.10. Corning Incorporated

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

22. Strategic Recommendations

23. About Us and Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global In-Vitro Fertilization Market, By Value, In USD Billion, 2017-2031F
  • Figure 2. Global In-Vitro Fertilization Market Share (%), By Products, 2017-2031F
  • Figure 3. Global In-Vitro Fertilization Market Share (%), By Type of Cycle, 2017-2031F
  • Figure 4. Global In-Vitro Fertilization Market Share (%), By Procedure, 2017-2031F
  • Figure 5. Global In-Vitro Fertilization Market Share (%), By Distribution, 2017-2031F
  • Figure 6. Global In-Vitro Fertilization Market Share (%), By Region, 2017-2031F
  • Figure 7. North America In-Vitro Fertilization Market, By Value, In USD Billion, 2017-2031F
  • Figure 8. North America In-Vitro Fertilization Market Share (%), By Products, 2017-2031F
  • Figure 9. North America In-Vitro Fertilization Market Share (%), By Type of Cycle, 2017-2031F
  • Figure 10. North America In-Vitro Fertilization Market Share (%), By Procedure, 2017-2031F
  • Figure 11. North America In-Vitro Fertilization Market Share (%), By Distribution, 2017-2031F
  • Figure 12. North America In-Vitro Fertilization Market Share (%), By Country, 2017-2031F
  • Figure 13. United States In-Vitro Fertilization Market, By Value, In USD Billion, 2017-2031F
  • Figure 14. United States In-Vitro Fertilization Market Share (%), By Products, 2017-2031F
  • Figure 15. United States In-Vitro Fertilization Market Share (%), By Type of Cycle, 2017-2031F
  • Figure 16. United States In-Vitro Fertilization Market Share (%), By Procedure, 2017-2031F
  • Figure 17. United States In-Vitro Fertilization Market Share (%), By Distribution, 2017-2031F
  • Figure 18. Canada In-Vitro Fertilization Market, By Value, In USD Billion, 2017-2031F
  • Figure 19. Canada In-Vitro Fertilization Market Share (%), By Products, 2017-2031F
  • Figure 20. Canada In-Vitro Fertilization Market Share (%), By Type of Cycle, 2017-2031F
  • Figure 21. Canada In-Vitro Fertilization Market Share (%), By Procedure, 2017-2031F
  • Figure 22. Canada In-Vitro Fertilization Market Share (%), By Distribution, 2017-2031F
  • Figure 23. Mexico In-Vitro Fertilization Market, By Value, In USD Billion, 2017-2031F
  • Figure 24. Mexico In-Vitro Fertilization Market Share (%), By Products, 2017-2031F
  • Figure 25. Mexico In-Vitro Fertilization Market Share (%), By Type of Cycle, 2017-2031F
  • Figure 26. Mexico In-Vitro Fertilization Market Share (%), By Procedure, 2017-2031F
  • Figure 27. Mexico In-Vitro Fertilization Market Share (%), By Distribution, 2017-2031F
  • Figure 28. Europe In-Vitro Fertilization Market, By Value, In USD Billion, 2017-2031F
  • Figure 29. Europe In-Vitro Fertilization Market Share (%), By Products, 2017-2031F
  • Figure 30. Europe In-Vitro Fertilization Market Share (%), By Type of Cycle, 2017-2031F
  • Figure 31. Europe In-Vitro Fertilization Market Share (%), By Procedure, 2017-2031F
  • Figure 32. Europe In-Vitro Fertilization Market Share (%), By Distribution, 2017-2031F
  • Figure 33. Europe In-Vitro Fertilization Market Share (%), By Country, 2017-2031F
  • Figure 34. Germany In-Vitro Fertilization Market, By Value, In USD Billion, 2017-2031F
  • Figure 35. Germany In-Vitro Fertilization Market Share (%), By Products, 2017-2031F
  • Figure 36. Germany In-Vitro Fertilization Market Share (%), By Type of Cycle, 2017-2031F
  • Figure 37. Germany In-Vitro Fertilization Market Share (%), By Procedure, 2017-2031F
  • Figure 38. Germany In-Vitro Fertilization Market Share (%), By Distribution, 2017-2031F
  • Figure 39. France In-Vitro Fertilization Market, By Value, In USD Billion, 2017-2031F
  • Figure 40. France In-Vitro Fertilization Market Share (%), By Products, 2017-2031F
  • Figure 41. France In-Vitro Fertilization Market Share (%), By Type of Cycle, 2017-2031F
  • Figure 42. France In-Vitro Fertilization Market Share (%), By Procedure, 2017-2031F
  • Figure 43. France In-Vitro Fertilization Market Share (%), By Distribution, 2017-2031F
  • Figure 44. Italy In-Vitro Fertilization Market, By Value, In USD Billion, 2017-2031F
  • Figure 45. Italy In-Vitro Fertilization Market Share (%), By Products, 2017-2031F
  • Figure 46. Italy In-Vitro Fertilization Market Share (%), By Type of Cycle, 2017-2031F
  • Figure 47. Italy In-Vitro Fertilization Market Share (%), By Procedure, 2017-2031F
  • Figure 48. Italy In-Vitro Fertilization Market Share (%), By Distribution, 2017-2031F
  • Figure 49. United Kingdom In-Vitro Fertilization Market, By Value, In USD Billion, 2017-2031F
  • Figure 50. United Kingdom In-Vitro Fertilization Market Share (%), By Products, 2017-2031F
  • Figure 51. United Kingdom In-Vitro Fertilization Market Share (%), By Type of Cycle, 2017-2031F
  • Figure 52. United Kingdom In-Vitro Fertilization Market Share (%), By Procedure, 2017-2031F
  • Figure 53. United Kingdom In-Vitro Fertilization Market Share (%), By Distribution, 2017-2031F
  • Figure 54. Russia In-Vitro Fertilization Market, By Value, In USD Billion, 2017-2031F
  • Figure 55. Russia In-Vitro Fertilization Market Share (%), By Products, 2017-2031F
  • Figure 56. Russia In-Vitro Fertilization Market Share (%), By Type of Cycle, 2017-2031F
  • Figure 57. Russia In-Vitro Fertilization Market Share (%), By Procedure, 2017-2031F
  • Figure 58. Russia In-Vitro Fertilization Market Share (%), By Distribution, 2017-2031F
  • Figure 59. Netherlands In-Vitro Fertilization Market, By Value, In USD Billion, 2017-2031F
  • Figure 60. Netherlands In-Vitro Fertilization Market Share (%), By Products, 2017-2031F
  • Figure 61. Netherlands In-Vitro Fertilization Market Share (%), By Type of Cycle, 2017-2031F
  • Figure 62. Netherlands In-Vitro Fertilization Market Share (%), By Procedure, 2017-2031F
  • Figure 63. Netherlands In-Vitro Fertilization Market Share (%), By Distribution, 2017-2031F
  • Figure 64. Spain In-Vitro Fertilization Market, By Value, In USD Billion, 2017-2031F
  • Figure 65. Spain In-Vitro Fertilization Market Share (%), By Products, 2017-2031F
  • Figure 66. Spain In-Vitro Fertilization Market Share (%), By Type of Cycle, 2017-2031F
  • Figure 67. Spain In-Vitro Fertilization Market Share (%), By Procedure, 2017-2031F
  • Figure 68. Spain In-Vitro Fertilization Market Share (%), By Distribution, 2017-2031F
  • Figure 69. Turkey In-Vitro Fertilization Market, By Value, In USD Billion, 2017-2031F
  • Figure 70. Turkey In-Vitro Fertilization Market Share (%), By Products, 2017-2031F
  • Figure 71. Turkey In-Vitro Fertilization Market Share (%), By Type of Cycle, 2017-2031F
  • Figure 72. Turkey In-Vitro Fertilization Market Share (%), By Procedure, 2017-2031F
  • Figure 73. Turkey In-Vitro Fertilization Market Share (%), By Distribution, 2017-2031F
  • Figure 74. Poland In-Vitro Fertilization Market, By Value, In USD Billion, 2017-2031F
  • Figure 75. Poland In-Vitro Fertilization Market Share (%), By Products, 2017-2031F
  • Figure 76. Poland In-Vitro Fertilization Market Share (%), By Type of Cycle, 2017-2031F
  • Figure 77. Poland In-Vitro Fertilization Market Share (%), By Procedure, 2017-2031F
  • Figure 78. Poland In-Vitro Fertilization Market Share (%), By Distribution, 2017-2031F
  • Figure 79. South America In-Vitro Fertilization Market, By Value, In USD Billion, 2017-2031F
  • Figure 80. South America In-Vitro Fertilization Market Share (%), By Products, 2017-2031F
  • Figure 81. South America In-Vitro Fertilization Market Share (%), By Type of Cycle, 2017-2031F
  • Figure 82. South America In-Vitro Fertilization Market Share (%), By Procedure, 2017-2031F
  • Figure 83. South America In-Vitro Fertilization Market Share (%), By Distribution, 2017-2031F
  • Figure 84. South America In-Vitro Fertilization Market Share (%), By Country, 2017-2031F
  • Figure 85. Brazil In-Vitro Fertilization Market, By Value, In USD Billion, 2017-2031F
  • Figure 86. Brazil In-Vitro Fertilization Market Share (%), By Products, 2017-2031F
  • Figure 87. Brazil In-Vitro Fertilization Market Share (%), By Type of Cycle, 2017-2031F
  • Figure 88. Brazil In-Vitro Fertilization Market Share (%), By Procedure, 2017-2031F
  • Figure 89. Brazil In-Vitro Fertilization Market Share (%), By Distribution, 2017-2031F
  • Figure 90. Argentina In-Vitro Fertilization Market, By Value, In USD Billion, 2017-2031F
  • Figure 91. Argentina In-Vitro Fertilization Market Share (%), By Products, 2017-2031F
  • Figure 92. Argentina In-Vitro Fertilization Market Share (%), By Type of Cycle, 2017-2031F
  • Figure 93. Argentina In-Vitro Fertilization Market Share (%), By Procedure, 2017-2031F
  • Figure 94. Argentina In-Vitro Fertilization Market Share (%), By Distribution, 2017-2031F
  • Figure 95. Asia-Pacific In-Vitro Fertilization Market, By Value, In USD Billion, 2017-2031F
  • Figure 96. Asia-Pacific In-Vitro Fertilization Market Share (%), By Products, 2017-2031F
  • Figure 97. Asia-Pacific In-Vitro Fertilization Market Share (%), By Type of Cycle, 2017-2031F
  • Figure 98. Asia-Pacific In-Vitro Fertilization Market Share (%), By Procedure, 2017-2031F
  • Figure 99. Asia-Pacific In-Vitro Fertilization Market Share (%), By Distribution, 2017-2031F
  • Figure 100. Asia-Pacific In-Vitro Fertilization Market Share (%), By Country, 2017-2031F
  • Figure 101. India In-Vitro Fertilization Market, By Value, In USD Billion, 2017-2031F
  • Figure 102. India In-Vitro Fertilization Market Share (%), By Products, 2017-2031F
  • Figure 103. India In-Vitro Fertilization Market Share (%), By Type of Cycle, 2017-2031F
  • Figure 104. India In-Vitro Fertilization Market Share (%), By Procedure, 2017-2031F
  • Figure 105. India In-Vitro Fertilization Market Share (%), By Distribution, 2017-2031F
  • Figure 106. China In-Vitro Fertilization Market, By Value, In USD Billion, 2017-2031F
  • Figure 107. China In-Vitro Fertilization Market Share (%), By Products, 2017-2031F
  • Figure 108. China In-Vitro Fertilization Market Share (%), By Type of Cycle, 2017-2031F
  • Figure 109. China In-Vitro Fertilization Market Share (%), By Procedure, 2017-2031F
  • Figure 110. China In-Vitro Fertilization Market Share (%), By Distribution, 2017-2031F
  • Figure 111. Japan In-Vitro Fertilization Market, By Value, In USD Billion, 2017-2031F
  • Figure 112. Japan In-Vitro Fertilization Market Share (%), By Products, 2017-2031F
  • Figure 113. Japan In-Vitro Fertilization Market Share (%), By Type of Cycle, 2017-2031F
  • Figure 114. Japan In-Vitro Fertilization Market Share (%), By Procedure, 2017-2031F
  • Figure 115. Japan In-Vitro Fertilization Market Share (%), By Distribution, 2017-2031F
  • Figure 116. Australia In-Vitro Fertilization Market, By Value, In USD Billion, 2017-2031F
  • Figure 117. Australia In-Vitro Fertilization Market Share (%), By Products, 2017-2031F
  • Figure 118. Australia In-Vitro Fertilization Market Share (%), By Type of Cycle, 2017-2031F
  • Figure 119. Australia In-Vitro Fertilization Market Share (%), By Procedure, 2017-2031F
  • Figure 120. Australia In-Vitro Fertilization Market Share (%), By Distribution, 2017-2031F
  • Figure 121. Vietnam In-Vitro Fertilization Market, By Value, In USD Billion, 2017-2031F
  • Figure 122. Vietnam In-Vitro Fertilization Market Share (%), By Products, 2017-2031F
  • Figure 123. Vietnam In-Vitro Fertilization Market Share (%), By Type of Cycle, 2017-2031F
  • Figure 124. Vietnam In-Vitro Fertilization Market Share (%), By Procedure, 2017-2031F
  • Figure 125. Vietnam In-Vitro Fertilization Market Share (%), By Distribution, 2017-2031F
  • Figure 126. South Korea In-Vitro Fertilization Market, By Value, In USD Billion, 2017-2031F
  • Figure 127. South Korea In-Vitro Fertilization Market Share (%), By Products, 2017-2031F
  • Figure 128. South Korea In-Vitro Fertilization Market Share (%), By Type of Cycle, 2017-2031F
  • Figure 129. South Korea In-Vitro Fertilization Market Share (%), By Procedure, 2017-2031F
  • Figure 130. South Korea In-Vitro Fertilization Market Share (%), By Distribution, 2017-2031F
  • Figure 131. Indonesia In-Vitro Fertilization Market, By Value, In USD Billion, 2017-2031F
  • Figure 132. Indonesia In-Vitro Fertilization Market Share (%), By Products, 2017-2031F
  • Figure 133. Indonesia In-Vitro Fertilization Market Share (%), By Type of Cycle, 2017-2031F
  • Figure 134. Indonesia In-Vitro Fertilization Market Share (%), By Procedure, 2017-2031F
  • Figure 135. Indonesia In-Vitro Fertilization Market Share (%), By Distribution, 2017-2031F
  • Figure 136. Philippines In-Vitro Fertilization Market, By Value, In USD Billion, 2017-2031F
  • Figure 137. Philippines In-Vitro Fertilization Market Share (%), By Products, 2017-2031F
  • Figure 138. Philippines In-Vitro Fertilization Market Share (%), By Type of Cycle, 2017-2031F
  • Figure 139. Philippines In-Vitro Fertilization Market Share (%), By Procedure, 2017-2031F
  • Figure 140. Philippines In-Vitro Fertilization Market Share (%), By Distribution, 2017-2031F
  • Figure 141. Middle East & Africa In-Vitro Fertilization Market, By Value, In USD Billion, 2017-2031F
  • Figure 142. Middle East & Africa In-Vitro Fertilization Market Share (%), By Products, 2017-2031F
  • Figure 143. Middle East & Africa In-Vitro Fertilization Market Share (%), By Type of Cycle, 2017-2031F
  • Figure 144. Middle East & Africa In-Vitro Fertilization Market Share (%), By Procedure, 2017-2031F
  • Figure 145. Middle East & Africa In-Vitro Fertilization Market Share (%), By Distribution, 2017-2031F
  • Figure 146. Middle East & Africa In-Vitro Fertilization Market Share (%), By Country, 2017-2031F
  • Figure 147. Saudi Arabia In-Vitro Fertilization Market, By Value, In USD Billion, 2017-2031F
  • Figure 148. Saudi Arabia In-Vitro Fertilization Market Share (%), By Products, 2017-2031F
  • Figure 149. Saudi Arabia In-Vitro Fertilization Market Share (%), By Type of Cycle, 2017-2031F
  • Figure 150. Saudi Arabia In-Vitro Fertilization Market Share (%), By Procedure, 2017-2031F
  • Figure 151. Saudi Arabia In-Vitro Fertilization Market Share (%), By Distribution, 2017-2031F
  • Figure 152. UAE In-Vitro Fertilization Market, By Value, In USD Billion, 2017-2031F
  • Figure 153. UAE In-Vitro Fertilization Market Share (%), By Products, 2017-2031F
  • Figure 154. UAE In-Vitro Fertilization Market Share (%), By Type of Cycle, 2017-2031F
  • Figure 155. UAE In-Vitro Fertilization Market Share (%), By Procedure, 2017-2031F
  • Figure 156. UAE In-Vitro Fertilization Market Share (%), By Distribution, 2017-2031F
  • Figure 157. South Africa In-Vitro Fertilization Market, By Value, In USD Billion, 2017-2031F
  • Figure 158. South Africa In-Vitro Fertilization Market Share (%), By Products, 2017-2031F
  • Figure 159. South Africa In-Vitro Fertilization Market Share (%), By Type of Cycle, 2017-2031F
  • Figure 160. South Africa In-Vitro Fertilization Market Share (%), By Procedure, 2017-2031F
  • Figure 161. South Africa In-Vitro Fertilization Market Share (%), By Distribution, 2017-2031F
  • Figure 162. By Products Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 163. By Type of Cycle Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 164. By Procedure Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 165. By Distribution Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 166. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023